Valeant Pharmaceuticals CEO J. Michael Pearson discusses an acquisition on CNBC (Screenshot from video)
23 Oct 2015

Pharma CEO Who Said He Only Cares About Shareholders Loses Them Money

Valeant CEO J. Michael Pearson let it be known that his company’s shareholders, not patients needing the company’s drugs, were his only real concern.

A screenshot from In The Public Interest's new report, "Buying Access: How Corporations Influence Decision Makers at Corrections Conferences, Trainings, and Meetings" showing  the business partners of a 2013 correctional association conference. (In The Public Interest)
07 Aug 2015

How Correctional Associations Help Corporations Buy Access To Prisons

A new report by In The Public Interest (ITPI) illustrates how private companies that operate prisons or services within prisons use correctional associations to gain intimate access to decision makers in government — almost entirely off the books. Private companies pay millions of dollars each year to attend their conferences, lead trainings and workshops, give speeches, and advertise their products and services to law enforcement officials in attendance.